Suppr超能文献

解决商业秘密保护对健康和权利带来的风险。

Addressing the Risks That Trade Secret Protections Pose for Health and Rights.

机构信息

2021 graduate of Yale Law School, New Haven, USA.

Lecturer at the Ateneo de Manila University School of Law, Makati, Philippines.

出版信息

Health Hum Rights. 2021 Jun;23(1):129-144.

Abstract

Human rights frameworks afford everyone the right to health and the right to enjoy the benefits of scientific progress and its applications. Both come together to create state obligations to ensure access to medicines and other health technologies. Though the impact of patents on access to high-quality, affordable medicines and health technologies has been well described, there has been little attention to the impact of trade secrecy law in this context. In this paper, we describe how trade secrecy protection comes into conflict with access to medicines-for example, by preventing researchers from accessing clinical trial data, undermining the scale-up of manufacturing in pandemics, and deterring whistleblowers from reporting industry misconduct. The paper proposes measures to diminish the conflict between trade secrecy and health that are consistent with international law and will advance health without undermining innovation.

摘要

人权框架赋予每个人享有健康的权利和享受科学进步及其应用成果的权利。这两者共同构成了国家确保获得药品和其他卫生技术的义务。尽管专利对获得高质量、负担得起的药品和卫生技术的影响已经得到了充分的描述,但在这方面,人们对贸易保密法的影响关注甚少。本文描述了贸易保密保护如何与获取药品产生冲突,例如,通过阻止研究人员获取临床试验数据、破坏大流行病期间的制造规模扩大,以及阻止举报人举报行业不当行为。本文提出了一些措施,以减少贸易保密与卫生之间的冲突,这些措施符合国际法,将在不损害创新的情况下促进卫生事业的发展。

相似文献

4
Patents and access to essential drugs.
Trans R Soc Trop Med Hyg. 2003 Jan-Feb;97(1):6-9. doi: 10.1016/s0035-9203(03)90002-2.
7
Patents and human rights: a heterodox analysis.
J Law Med Ethics. 2013 Spring;41(1):185-98. doi: 10.1111/jlme.12013.

引用本文的文献

1
Defining a malaria diagnostic pathway from innovation to adoption: Stakeholder perspectives on data and evidence gaps.
PLOS Glob Public Health. 2024 May 16;4(5):e0002957. doi: 10.1371/journal.pgph.0002957. eCollection 2024.
4
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
IIC Int Rev Ind Prop Copyr Law. 2023;54(5):732-763. doi: 10.1007/s40319-023-01329-4. Epub 2023 May 4.

本文引用的文献

1
A manifesto for reproducible science.
Nat Hum Behav. 2017 Jan 10;1(1):0021. doi: 10.1038/s41562-016-0021.
2
Confidentiality Orders and Public Interest in Drug and Medical Device Litigation.
JAMA Intern Med. 2020 Feb 1;180(2):292-299. doi: 10.1001/jamainternmed.2019.5161.
4
Reinstitutionalizing transparency at Health Canada.
CMAJ. 2015 Dec 22;188(3):218-9. doi: 10.1503/cmaj.150765.
7
Data dredging, bias, or confounding.
BMJ. 2002 Dec 21;325(7378):1437-8. doi: 10.1136/bmj.325.7378.1437.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验